Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adnan Tufail

Showing results (11-20 of 255) with videos related to

Pageof 26
Sort By:
JAMA Ophthalmology|February 20, 2015
Paracentral acute middle maculopathy in sickle cell diseaseTomas Ilginis, Pearse A Keane, Adnan Tufail
The British Journal of Ophthalmology|September 29, 2019
Visual benefit versus visual gain: what is the effect of baseline covariants in the treatment arm relative to the control arm? A pooled analysis of ANCHOR and MARINAAdnan Tufail, Philippe Margaron, Tadhg Guerin, et al.
BMJ Open|May 7, 2015
The cost-effectiveness of initiating ranibizumab therapy in eyes with neovascular AMD with good vision: an economic model using real-world outcomesThomas Butt, Aaron Lee, Cecilia Lee, et al.
European Journal of Ophthalmology|April 11, 2018
A 12-month, multicenter, parallel group comparison of dexamethasone intravitreal implant versus ranibizumab in branch retinal vein occlusionFrancesco Bandello, Albert Augustin, Adnan Tufail, et al.
Journal of Ophthalmology|December 17, 2011
Management of neovascular age-related macular degeneration in clinical practice: initiation, maintenance, and discontinuation of therapyPearse A Keane, Adnan Tufail, Praveen J Patel
Ophthalmology|November 22, 2017
Machine Learning Has Arrived!Aaron Lee, Paul Taylor, Jayashree Kalpathy-Cramer, et al.
Ophthalmology|October 23, 2018
ReplyAaron Lee, Paul Taylor, Jayashree Kalpathy-Cramer, et al.
Survey of Ophthalmology|April 20, 2015
The other CNVM: a review of myopic choroidal neovascularization treatment in the age of anti-vascular endothelial growth factor agentsFeisal A Adatia, Micah Luong, Monique Munro, et al.
Retinal Cases & Brief Reports|November 13, 2014
Radiation maculopathy complicated by intraretinal neovascularization treated with intravitreal bevacizumabWaheeda Rahman, Nachiketa Acharya, Mandeep S Sagoo, et al.
Expert Opinion on Biological Therapy|March 18, 2016
Vascular endothelial growth factor inhibitor use and treatment approach for choroidal neovascularization secondary to pathologic myopiaKaivon Pakzad-Vaezi, Hemal Mehta, Zaid Mammo, et al.
Pageof 26

Showing results (11-20 of 255) with videos related to

Sort By:
Pageof 26
JAMA Ophthalmology|February 20, 2015
Paracentral acute middle maculopathy in sickle cell diseaseTomas Ilginis, Pearse A Keane, Adnan Tufail
The British Journal of Ophthalmology|September 29, 2019
Visual benefit versus visual gain: what is the effect of baseline covariants in the treatment arm relative to the control arm? A pooled analysis of ANCHOR and MARINAAdnan Tufail, Philippe Margaron, Tadhg Guerin, et al.
BMJ Open|May 7, 2015
The cost-effectiveness of initiating ranibizumab therapy in eyes with neovascular AMD with good vision: an economic model using real-world outcomesThomas Butt, Aaron Lee, Cecilia Lee, et al.
European Journal of Ophthalmology|April 11, 2018
A 12-month, multicenter, parallel group comparison of dexamethasone intravitreal implant versus ranibizumab in branch retinal vein occlusionFrancesco Bandello, Albert Augustin, Adnan Tufail, et al.
Journal of Ophthalmology|December 17, 2011
Management of neovascular age-related macular degeneration in clinical practice: initiation, maintenance, and discontinuation of therapyPearse A Keane, Adnan Tufail, Praveen J Patel
Ophthalmology|November 22, 2017
Machine Learning Has Arrived!Aaron Lee, Paul Taylor, Jayashree Kalpathy-Cramer, et al.
Ophthalmology|October 23, 2018
ReplyAaron Lee, Paul Taylor, Jayashree Kalpathy-Cramer, et al.
Survey of Ophthalmology|April 20, 2015
The other CNVM: a review of myopic choroidal neovascularization treatment in the age of anti-vascular endothelial growth factor agentsFeisal A Adatia, Micah Luong, Monique Munro, et al.
Retinal Cases & Brief Reports|November 13, 2014
Radiation maculopathy complicated by intraretinal neovascularization treated with intravitreal bevacizumabWaheeda Rahman, Nachiketa Acharya, Mandeep S Sagoo, et al.
Expert Opinion on Biological Therapy|March 18, 2016
Vascular endothelial growth factor inhibitor use and treatment approach for choroidal neovascularization secondary to pathologic myopiaKaivon Pakzad-Vaezi, Hemal Mehta, Zaid Mammo, et al.
Pageof 26